This traditional poster session showcases quantitative and multiparametric neuroimaging approaches for detecting tissue damage, monitoring disease evolution, and predicting clinical outcomes in neuroinflammation, with a strong focus on multiple sclerosis. Presentations highlight diffusion MRI, quantitative T1/PD mapping, myelin-sensitive techniques, and multiparametric biomarkers to characterize demyelination, remyelination, and early tissue injury. Several posters also explore functional reorganization, network alterations, and AI-accelerated imaging across related neurological and systemic conditions. Together, the session emphasizes the clinical and biological value of quantitative MRI for earlier detection, better phenotyping, and improved prognostication.